Moreover, neoadjuvant CRT leads to increased recruitment of CD8+ T-cells within the tumor microenvironment, and high CD8+ T-cell density has been significantly associated with improved DFS after neoadjuvant CRT (p = 0.039) [39]. This evidence concerns the gene CD8A and neoplasm.